M. Nakashima

发表

Epidermal Growth Factor (EGF) Receptor Kinase Activity is Required for Tumor Necrosis Factor (TNF)-α Mediated Intestinal Epithelial Survival

M. Adachi, S. Kusumoto, D. Polk, 2009 .

Effectiveness of intensive follow-up after response in patients with small cell lung cancer.

M. Adachi, S. Kusumoto, T. Hirose, 2008, Lung cancer.

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

M. Adachi, S. Kusumoto, T. Hirose, 2010, Cancer Chemotherapy and Pharmacology.

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

S. Kusumoto, K. Shiraishi, K. Kaira, 2021, Therapeutic advances in medical oncology.

Comparison of Biweekly and Triweekly Therapy with Docetaxel and Irinotecan for Refractory or Relapsed Advanced Non-small-cell Lung cancer

M. Adachi, S. Kusumoto, N. Horichi, 2007 .

Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.

S. Kusumoto, T. Hirose, H. Ishida, 2012, Anticancer research.

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

M. Adachi, S. Kusumoto, T. Hirose, 2007, Cancer Chemotherapy and Pharmacology.

The Correlation of Cathepsin D and Ki-67 Expression with 5-year Survival in Small-sized Papillary Adenocarcinoma Cases

T. Morohoshi, Hirotaka Kato, M. Nonaka, 2003 .

Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma

M. Adachi, T. Morohoshi, N. Ohike, 2004, Journal of Cancer Research and Clinical Oncology.

Proliferating and Invasive Growth Potentials of Type-D and F Pulmonary Adenocarcinoma: Correlation with Lymph Node Involvement in T1 Cases

M. Wada, T. Morohoshi, T. Kunimura, 2001 .

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

T. Kaku, H. Nakano, T. Hirakawa, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Drug Accumulation and Efflux Do not Contribute to Acquired Gefitinib Resistance

N. Saijo, K. Nishio, T. Kuroki, 2009 .

High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer.

S. Kusumoto, Y. Sasaki, Ken-Ichi Fujita, 2014, Lung cancer.

Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases

T. Abe, M. Nakashima, Norifumi Yoshida, 2022, PloS one.

COVID-19-Associated Pulmonary Aspergillosis in a Patient Treated With Remdesivir, Dexamethasone, and Baricitinib: A Case Report

A. Shimada, A. Nagai, M. Nakashima, 2022, Cureus.

Pneumonia induced by eribulin mesylate in a patient with recurrent breast cancer

T. Homma, S. Kusumoto, T. Hirose, 2013, International Cancer Conference Journal.

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis

Y. Fukuda, K. Shiraishi, K. Kaira, 2022, Therapeutic advances in medical oncology.

Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.

M. Adachi, S. Kusumoto, T. Hirose, 2009, Anticancer research.

Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer.

M. Adachi, S. Kusumoto, T. Hirose, 2010, European journal of cancer.

Subsequent Loss of the Proliferated Pancreatic Ductulus in Experimental Pancreatitis: Is it Caused by Apoptosis?

M. Wada, T. Kunimura, H. Ishino, 2001 .

Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer.

S. Kusumoto, Y. Sasaki, Ken-Ichi Fujita, 2016, Lung cancer.

Cytopathologic and Histologic Features of Biphasic Pulmonary Blastoma

M. Adachi, T. Morohoshi, M. Kushima, 2005, Acta Cytologica.

Patient satisfaction with sedation for flexible bronchoscopy

M. Adachi, S. Kusumoto, T. Hirose, 2008, Respirology.

Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer.

M. Adachi, S. Kusumoto, T. Hirose, 2011, Lung cancer.

The Cellular Source of Hepatic Periductal Mesenchymal Cells in Biliary Atresia

M. Kojima, M. Wada, T. Morohoshi, 2003 .

Evaluation of the Efficacy and Safety of the Combination of Gemcitabine and Nedaplatin for Elderly Patients with Advanced Non-Small-Cell Lung Cancer

S. Kusumoto, Y. Murata, T. Hirose, 2011, Oncology.

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer.

S. Kusumoto, T. Hirose, H. Ishida, 2014, Molecular and clinical oncology.

Phosphatase of Regenerating Liver-1 Promotes Cell Migration and Invasion and Regulates Filamentous Actin Dynamics

J. Lazo, M. Nakashima, 2010, Journal of Pharmacology and Experimental Therapeutics.

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.

K. Kubota, T. Harada, N. Seki, 2021, Lung cancer.

Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma

M. Wada, T. Morohoshi, Hirotaka Kato, 2003, International journal of gastrointestinal cancer.

Cyopathologic and histologic features of biphasic pulmonary blastoma: a case report.

M. Adachi, T. Morohoshi, M. Kushima, 2005, Acta Cytologica.

Patient satisfaction with sedation for flexible bronchoscopy

M. Adachi, S. Kusumoto, T. Hirose, 2008, Respirology.